Colorectal cancer now leads cancer deaths in adults under 50, with cases rising since 1995. Learn when to start screening and recognize key symptoms to protect yourself.
Ulcerative colitis is a long-term disease that causes inflammation in the large intestine. It can lead to abdominal pain, diarrhea, bleeding, fatigue, and weight loss. For many people, the disease ...
We live in a chaotic and often stressful world. Whether your dog is feeling stress from his environment or even smelling (and ...
A novel immunotherapy combination is proving to be both safe and manageable for patients with prostate cancer, according to updated Phase 1 trial data presented at the 2026 ASCO Genitourinary Cancers ...
Everyday Health on MSN
Ulcerative colitis and urgency: What you can do about it
ON THIS PAGEWhy Urgency Happens in UCSolutions for UC UrgencyWhen Urgency Is a Bigger ProblemMore than80 percent of people with ulcerative colitis (UC) experience bowel urgency that overwhelming, need ...
Everyday Health on MSN
Fulminant colitis: When an ulcerative colitis flare becomes a medical emergency
ON THIS PAGESymptomsComplicationsWhy Fulminant Colitis OccursWhat to Do During a Severe UC FlareAfter a Fulminant UC EpisodeFor some people with ulcerative colitis (UC), the symptoms are mild. But for ...
Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.
Women are more likely to experience delays in receiving an accurate IBD diagnosis. IBD can affect your menstrual cycle, and hormone changes may change how you respond to treatment. Menstrual bleeding ...
The six-year-old Rippin For The Cure campaign has attracted donations from the New York Jets, Giants and Philadelphia Flyers, ...
New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...
Inflammatory bowel disease, often called IBD, is a long-term condition that causes ongoing inflammation in the digestive system. The two main types are Crohn’s disease and ulcerative colitis. People ...
Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果